What is the Cptac database?
The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.
What is the study of proteomics?
Proteomics is the large-scale study of proteomes. A proteome is a set of proteins produced in an organism, system, or biological context. We may refer to, for instance, the proteome of a species (for example, Homo sapiens) or an organ (for example, the liver).
What new efforts are being done by Cptac in the field of cancer proteogenomics?
CPTAC is currently leveraging its investment in cancer proteogenomics by characterizing additional cancer types, expanding its application through open-source community resources, and accelerating precision oncology by applying proteogenomics to questions of toxicity and resistance in clinical trials.
What is cancer proteomics?
Cancer proteomics encompasses the identification and quantitative analysis of differentially expressed proteins relative to healthy tissue counterparts at different stages of disease, from preneoplasia to neoplasia.
What is the aim of proteomics?
Proteomics aims to identify the subcellular location of each protein. This information can be used to create a 3-D protein map of the cell, providing novel information about protein regulation.
Why is proteomics important in cancer research?
The proteomics approach has become popular in cancer studies. Proteomics-based technologies have enabled the identification of potential biomarkers and protein expression patterns that can be used to assess tumor prognosis, prediction, tumor classification, and to identify potential responders for specific therapies.
How is proteomics used in drug discovery?
Common applications of proteomics in the drug industry include target identification and validation, identification of efficacy and toxicity biomarkers from readily accessible biological fluids, and investigations into mechanisms of drug action or toxicity.
How is proteomics used in cancer treatment?
What are some benefits of proteomics?
Benefits of Proteomics Given the number of proteins that can be produced by individual organisms, it seems that proteomics may allow greater understanding of the complexity of life and the process of evolution than the study of the genetic code alone.
What are the major components of the Proteogenomics study?
Proteogenomics applications
- Novel protein-coding regions.
- Short open reading frames and new translation initiation sites.
- Alternative splicing.
- Sequence variants.
- Other sources of genome variation.
- Non-model organisms.
- Metaproteomics.
What is Protogenome?
To call these RNAs ‘genomes’ is a little fanciful, but the term protogenome has attractions as a descriptor for molecules that are self-replicating and able to direct simple biochemical reactions.
What is the difference between a genome and a proteome?
The genome is the sum total of genetic information encoded in the organism which is also called genotype of that organism, while the proteome is the outcome of the interaction between environment and the genome which is called phenotype.
What are proteomic techniques?
(A) Most techniques currently used in proteomics involve the separation of the vast number of proteins present in a cell or tissue at a given time prior to analysis by MS and recognition and characterization using bioinformatics techniques. The protein separation can be performed at the protein or peptide level.